Skip to Content

Consensi Approval History

  • FDA approved: Yes (First approved May 31st, 2018)
  • Brand name: Consensi
  • Generic name: amlodipine and celecoxib
  • Dosage form: Tablets
  • Company: Kitov Pharma Ltd.
  • Treatment for: High Blood Pressure, Osteoarthritis

Consensi (amlodipine and celecoxib) is a calcium channel blocker and nonsteroidal anti-inflammatory drug combination for the treatment of both hypertension and pain associated with osteoarthritis.

Development History and FDA Approval Process for Consensi

DateArticle
May 31, 2018Approval FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
Oct  2, 2017Kitov Announces Filing by FDA of New Drug Application for KIT-302
Jul 31, 2017Kitov Submits New Drug Application to FDA for KIT-302
Jun 26, 2017Kitov Updates on KIT-302 New Drug Application

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide